Associate Professor, Obstetrics and Gynecology, Washington University School of Medicine
Obstetrics & Gynecology
Dr. Premal H. Thaker, MD
|
|
Give Review
Premal H. Thaker practices Obstetrics & Gynecology. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACOG)". Premal Thaker is also published. He has 64 publications published. The lastest publication: "Lipid production by Candida Y-1.' Premal Thaker accepts Medicare payments and is registered with Medicare.gov.
Publications
- Intensity modulated radiation therapy for recurrent ovarian Cancer refractory to chemotherapy.
- Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial Cancer on genetic counseling and testing.
- Diurnal cortisol and survival in epithelial ovarian Cancer.
- Targeting those with decreased meaning and peace: a supportive care opportunity.
- Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Stage IV Uterine Serous Carcinoma.
- Pre-operative Assessment of Muscle Mass to Predict Surgical Complications and Prognosis in Patients With Endometrial Cancer.
- Etiology and Workup of Fevers in Gynecologic Oncology Patients.
- Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial Cancer.
- Postradiation Damage to the Pelvic Girdle in Cervical Cancer Patients: Is Intensity-Modulated Radiation Therapy Safer Than Conventional Radiation?
- Disclosing a Diagnosis of Cancer: Considerations Specific to Gynecologic Oncology Patients.
- Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Non-Cancer life stressors contribute to impaired quality of life in ovarian Cancer patients.
- Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal Carcinoma.
- Sleep disturbance, distress, and quality of life in ovarian Cancer patients during the first year after diagnosis.
- Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent Cervical cancer.
- Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?
- Low yield of residual vulvar Carcinoma and dysplasia upon re-excision for close or positive margins.
- Cortisol and inflammatory processes in ovarian Cancer patients following primary treatment: Relationships with depression, fatigue, and disability.
- Lithium chloride and inhibition of glycogen synthase kinase 3? as a potential therapy for serous ovarian Cancer.
- Importance of adrenergic pathways in women's Cancers.
- Wilms' Tumor 1 Protein and Estrogen Receptor Beta Expression are Associated with Poor Outcomes in Uterine Carcinosarcoma.
- The utility and management of vaginal cytology after treatment for endometrial Cancer.
- Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial Cancer.
- Uteroenteric Fistula after uterine artery embolization.
- Work related stress among gynecologic oncologists.
- The Utility of Peritoneal Biopsy and Omentectomy in the Upstaging of Apparent Early Ovarian Cancer.
- Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial Carcinoma.
- Wound complications after gynecologic Cancer surgery.
- Aberrant Methylation of the X-Linked Ribosomal S6 Kinase RPS6KA6 (RSK4) in Endometrial Cancers.
- DICER1 expression and outcomes in endometrioid endometrial adenoCarcinoma.
- Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making.
- The effects of body mass index on complications and survival outcomes in patients with cervical Carcinoma undergoing curative chemoradiation therapy.
- Chemoradiation in locally advanced cervical Carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
- "Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian Cancer.
- The value of perioperative imaging in patients with Uterine sarcomas.
- Effects of Cancer treatment on ovarian function.
- The role of PET/CT in the management of patients with Cervical cancer: practice patterns of the members of the Society of Gynecologic Oncologists.
- ATR mutation in endometrioid endometrial Cancer is associated with poor clinical outcomes.
- Functional significance of VEGFR-2 on ovarian Cancer cells.
- Surveillance FDG-PET detection of Asymptomatic recurrences in patients with cervical cancer.
- Impact of vessel maturation on antiangiogenic therapy in ovarian Cancer.
- Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian Cancer.
- Long-term PostMenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
- Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian Cancer.
- The neuroendocrine impact of chronic stress on Cancer.
- Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian Cancer.
- Analysis of EphA2 expression and mutant p53 in ovarian Carcinoma.
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian Carcinoma.
- Stress hormone-mediated invasion of ovarian Cancer cells.
- Inhibition of experimental colon Cancer metastasis by the GABA-receptor agonist nembutal.
- Antivascular therapy for orthotopic human ovarian Carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
- Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of Human co...
- EphA2 expression is associated with aggressive features in ovarian Carcinoma.
- Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial Cancer.
- Lipid production by Candida Y-1.
- Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate Cancer in the prostate...
- Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
- Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic Carcinoma in nude mice.
- Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian Cancer.
- Value of HPV testing in follow-up of treated high-risk CIN1: a study by Alonso et al.
- Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis.
- Neuroendocrine influences on Cancer biology.
- Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
Schools
Medical College of Pennsylvania
McP Hahnemann University
University Of Pa Health System
Procedures Preformed
- Colpopexy
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACOG)
Education
-
University of Pennsylvania Health System -
Drexel University - Hahnemann University Hospital
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1891739173 | |
| NPPES Provider LastName | THAKER | |
| NPPES Provider FirstName | PREMAL | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 223.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 5.83 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891739173 |
| Last Name Of The Provider | THAKER |
| First Name Of The Provider | PREMAL |
| View All |
Similar Doctors
|
|
Dr. Scott W. Biest, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tammy S. Sonn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Francisco P. Xynos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy C. Philpott, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Becky R. Shelton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ming Shian Kao, MD |
|
|
Dr. Mario A. Coronado, MD |
|
|
Dr. Alaa A. Elbendary, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William J. Ott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cyril W. Helm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nishan H. Chobanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mario A. Salinas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura K. Eastep, MD |
|
|
Dr. Karuna P. Murray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Distasio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew E. Galakatos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelle H. Moley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alfredo J. Jijon, MD |